LYVE1 and neoplasm: The fact that PROX1 controls the expression of several lymphatic transcription factors, including vascular endothelial growth factors (VEGFs) and the lymphatic vessel endothelial hyaluronan receptor-1 (LYVE-1), demonstrates the correlations between PROX1 expression and lymphovascular invasion, tumor invasion, and metastasis.